What are the indications for blood transfusion in children?

Indications for Blood Transfusion in Children

In children over 3 months of age who are hemodynamically stable and not actively bleeding, use a restrictive red blood cell (RBC) transfusion threshold of hemoglobin <70 g/L, with higher thresholds reserved for specific high-risk conditions including mechanical ventilation, severe cardiac disease, acute brain injury, and active hemorrhage 1.

Red Blood Cell Transfusion Thresholds by Clinical Context

Stable, Non-Bleeding Children (>3 months)

• Hemoglobin threshold: <70 g/L for almost all stable children 1
• This restrictive approach is supported by evidence showing no benefit from liberal transfusion strategies in critically ill children
• Transfuse 10 ml/kg of RBCs, which typically increases hemoglobin by approximately 20 g/L 1

Preterm Neonates (<30 weeks gestation)

The most recent evidence provides specific algorithmic guidance 2:

Without respiratory support:

• Use restrictive thresholds based on postnatal age
• These thresholds are lower than historically used

With respiratory support (mechanical ventilation, CPAP, NIPPV, or nasal cannula ≥1 L/min):

• Use higher hemoglobin thresholds
• The TOP and ETTNO trials demonstrated that restrictive strategies (lower thresholds) showed no mortality or morbidity disadvantage compared to liberal strategies 2
• Transfuse 10-20 ml/kg over 3-4 hours 2

Higher Threshold Situations (Hemoglobin <75-90 g/L)

Acute brain injury:

• Recent TRAIN trial showed liberal strategy (threshold <90 g/L) associated with more favorable neurological outcomes at 6 months compared to restrictive (<70 g/L) 1
• Consider maintaining hemoglobin >70-90 g/L depending on severity

Cardiac surgery:

• Threshold of 75 g/L is reasonable based on pooled data from eight RCTs 1
• Use individualized markers: lactate, cerebral NIRS, central venous oxygen saturation 1

Septic shock, post-cardiac surgery, hemodynamic instability:

• Maintain hemoglobin >70 g/L at minimum 1
• Monitor central venous oxygen saturation and lactate clearance

Congenital heart disease:

• Higher thresholds often applied, though moderately restrictive thresholds can reduce transfusion volumes without adverse outcomes 1

Neonatal-Specific Requirements

• Use cytomegalovirus-negative blood components 1
• Components must be specified for neonatal use
• Critical caveat: Recommendations may not apply to acutely or severely ill neonates 2

Other Blood Component Dosing in Children

Prescribe by volume, not units 1:

• Fresh Frozen Plasma (FFP): 10-15 ml/kg

  • Main indication: major hemorrhage (often 1:1 or 1:1.5 ratio with RBCs)
  • Also for DIC with bleeding, warfarin reversal if PCC unavailable

• Platelets: 10-20 ml/kg 1

• Cryoprecipitate: 5-10 ml/kg 1

• Fibrinogen concentrate: 70 mg/kg (max 2 g); increase to 100 mg/kg in severe bleeding with hypofibrinogenemia 1

• Tranexamic acid: Use in major surgery (cardiac, scoliosis, craniosynostosis) and major trauma as part of massive hemorrhage protocols 1

Critical Practice Points

Single-Unit Strategy

• Transfuse one unit (or weight-based equivalent) at a time in stable patients 1
• Measure hemoglobin before and after each unit
• Reassess clinically between units

Volume Calculation Formula

When precise dosing needed 1:

Volume (ml) = [(Desired Hb - Actual Hb) × Weight (kg) × 3] / Hb of unit

Common Pitfalls to Avoid

1. Do not transfuse prophylactically to correct laboratory values alone without clinical indication 1
2. Avoid extrapolating adult data directly to children—physiology and pathology differ significantly 3
3. Do not use liberal thresholds in surgical settings without specific indication—surgical patients often receive transfusions at higher thresholds than necessary 4
4. Measure hemoglobin concentration (preferred over hematocrit) as it better reflects oxygen-carrying capacity 2

Monitoring Beyond Hemoglobin

Alternative markers when hemoglobin alone insufficient 1:

• Central venous oxygen saturation
• Lactate clearance and acidemia
• Tachycardia, hypotension, ECG changes
• Note: These lack sensitivity/specificity and normal values don't exclude inadequate oxygen delivery

Evidence Quality Considerations

The strongest contemporary evidence comes from the TOP and ETTNO trials for preterm neonates 2, and the 2025 Association of Anaesthetists guidelines provide the most comprehensive pediatric transfusion framework 1. However, significant variability exists across disciplines 4, and evidence remains limited outside intensive care and hematology-oncology settings 3, 4. The restrictive approach is favored given the absence of clear benefit from liberal transfusion and the desire to avoid transfusion-associated adverse events 2, 1.